Show simple item record

 
dc.contributorInstitut d'Assistència Sanitària
dc.contributor.authorLópez-Pousa, Secundino
dc.contributor.authorLombardía-Fernández, Cristina
dc.contributor.authorGarre-Olmo, Josep
dc.contributor.authorMonserrat-Vila, Sílvia
dc.contributor.authorVilalta-Franch, Joan
dc.contributor.authorCalvó-Perxas, Laia
dc.date.accessioned2021-11-22T13:01:30Z
dc.date.available2021-11-22T13:01:30Z
dc.date.issued2012-11-03
dc.identifier.citationLópez-Pousa S, Lombardía-Fernández C, Garre Olmo J, Monserrat-Vila S, Vilalta-Franch J, Calvó-Perxas L. Dopaminergic dysregulation, artistic expressiveness, and Parkinson’s disease. Case Rep Neurol. 2012 Set; 4(3):159-66.
dc.identifier.issn1662-680X
dc.identifier.urihttp://hdl.handle.net/11351/6578
dc.descriptionDopamine dysregulation; Parkinson’s disease; Art
dc.description.abstractBackground: The most frequent behavioral manifestations in Parkinson's disease (PD) are attributed to the dopaminergic dysregulation syndrome (DDS), which is considered to be secondary to the iatrogenic effects of the drugs that replace dopamine. Over the past few years some cases of patients improving their creative abilities after starting treatment with dopaminergic pharmaceuticals have been reported. These effects have not been clearly associated to DDS, but a relationship has been pointed out. Methods: Case study of a patient with PD. The evolution of her paintings along medication changes and disease advance has been analyzed. Results: The patient showed a compulsive increase of pictorial production after the diagnosis of PD was made. She made her best paintings when treated with cabergolide, and while painting, she reported a feeling of well-being, with loss of awareness of the disease and reduction of physical limitations. Conclusions: Dopaminergic antagonists (DA) trigger a dopaminergic dysfunction that alters artistic creativity in patients having a predisposition for it. The development of these skills might be due to the dopaminergic overstimulation due to the therapy with DA, which causes a neurophysiological alteration that globally determines DDS.
dc.language.isoeng
dc.publisherKarger Publishers
dc.relation.ispartofseriesCase Reports in Neurology;4(3)
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 International
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/
dc.sourceScientia
dc.subjectParkinson, Malaltia de
dc.subjectCreativitat
dc.subjectDopamina - Receptors
dc.subject.meshReceptors, Dopamine
dc.subject.meshParkinson Disease
dc.subject.meshCreativity
dc.titleDopaminergic dysregulation, artistic expressiveness, and Parkinson’s disease
dc.typeinfo:eu-repo/semantics/article
dc.identifier.doi10.1159/000343946
dc.subject.decsreceptores de dopamina
dc.subject.decsenfermedad de Parkinson
dc.subject.decscreatividad
dc.relation.publishversionhttps://doi.org/10.1159/000343946
dc.type.versioninfo:eu-repo/semantics/publishedVersion
dc.audienceProfessionals
dc.event.productorBiblioteca
dc.contributor.authoraffiliation[López-Pousa S, Vilalta-Franch J] Unitat de Recerca, Institut d’Assistència Sanitària, Salt, Spain. Unitat de Valoració de la Memòria i les Demències, Hospital Santa Caterina, Salt , Spain. [Lombardía-Fernández C, Montserrat-Vila S, Calvó-Perxas L] Unitat de Recerca, Institut d’Assistència Sanitària, Salt, Spain. [Garre Olmo J] Unitat de Recerca, Institut d’Assistència Sanitària, Salt, Spain. Departament de Psicologia, Universitat de Girona, Girona, Spain
dc.identifier.pmid23185168
dc.rights.accessrightsinfo:eu-repo/semantics/openAccess


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record